Quick Answer
NovaBridge Biosciences reported Stockholders Equity of $201.16 million for the year ending 2024.
- NovaBridge Biosciences showed a decrease of -17.1% in Stockholders Equity from 2023 to 2024.
- This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 3, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2024), NovaBridge Biosciences's Stockholders Equity has grown by 1,486.2%.
- Historical annual values: Fiscal year 2024: $201.16 million | Fiscal year 2023: $242.58 million | Fiscal year 2022: $417.81 million | Fiscal year 2021: $715.15 million | Fiscal year 2020: $5.63 billion | Fiscal year 2019: -$2.03 billion | Fiscal year 2018: -$955.10 million | Fiscal year 2017: -$299.80 million | Fiscal year 2016: -$14.51 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: